Sunday, December 2, 2018

Sun Pharma plunges 10% as SEBI plans to reopen insider trading case

Sun Pharma plunges 10% as SEBI plans to reopen insider trading case Sun Pharma, along with its Managing Director Dilip Shanghvi, and nine others had settled the insider trading probe, paying Rs 18 lakh against the settlement charges in 2017

from Moneycontrol Business News https://ift.tt/2Q9ybrR

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...